Neoleukin Therapeutics Inc (OQ:NLTX)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for NLTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 20/19 Dec 20/19 Baker Bros. Advisors Lp Indirect Ownership Pre-funded Warrants A - Grant, award or other under Rule 16b-3(d) 9,765,333  
Dec 20/19 Dec 20/19 Baker Bros. Advisors Lp Indirect Ownership Pre-funded Warrants A - Grant, award or other under Rule 16b-3(d) 1,160,148  
Dec 20/19 Dec 20/19 Baker Bros. Advisors Lp Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -9,765,333  
Dec 20/19 Dec 20/19 Baker Bros. Advisors Lp Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -1,160,148  
Dec 20/19 Dec 20/19 Baker Bros. Advisors Lp Indirect Ownership Common Stock P - Open market or private purchase 2,767,505 $8.40
Dec 20/19 Dec 20/19 Baker Bros. Advisors Lp Indirect Ownership Common Stock P - Open market or private purchase 250,037 $8.40
Dec 20/19 Dec 20/19 Drachman Jonathan G Direct Ownership Common Stock P - Open market or private purchase 119,047 $8.40
Dec 20/19 Nov 12/19 Drachman Jonathan G Direct Ownership Common Stock C - Conversion 1,261,600  
Dec 20/19 Nov 12/19 Drachman Jonathan G Direct Ownership Series A Preferred Stock C - Conversion -12,616  
Oct 15/19 Oct 10/19 Baker Bros. Advisors Lp Indirect Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 22,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for NLTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 20/19 Dec 20/19 Baker Bros. Advisors Lp Indirect Ownership Pre-funded Warrants A - Grant, award or other under Rule 16b-3(d) 9,765,333  
Dec 20/19 Dec 20/19 Baker Bros. Advisors Lp Indirect Ownership Pre-funded Warrants A - Grant, award or other under Rule 16b-3(d) 1,160,148  
Dec 20/19 Dec 20/19 Baker Bros. Advisors Lp Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -9,765,333  
Dec 20/19 Dec 20/19 Baker Bros. Advisors Lp Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -1,160,148  
Dec 20/19 Dec 20/19 Baker Bros. Advisors Lp Indirect Ownership Common Stock P - Open market or private purchase 2,767,505 $8.40
Dec 20/19 Dec 20/19 Baker Bros. Advisors Lp Indirect Ownership Common Stock P - Open market or private purchase 250,037 $8.40
Dec 20/19 Dec 20/19 Drachman Jonathan G Direct Ownership Common Stock P - Open market or private purchase 119,047 $8.40
Dec 20/19 Nov 12/19 Drachman Jonathan G Direct Ownership Common Stock C - Conversion 1,261,600  
Dec 20/19 Nov 12/19 Drachman Jonathan G Direct Ownership Series A Preferred Stock C - Conversion -12,616  
Oct 15/19 Oct 10/19 Baker Bros. Advisors Lp Indirect Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 22,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $NLTX

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)